Comparison of methods for concentrating winterised cannabis extract
Genevac compares use of a rotary evaporator and the Genevac Rocket Synergy evaporator, for the batch concentration of 2 L of winterised cannabis extract in ethanol.
Genevac has posted a YouTube video of a demo at California Gold Extractions (San Diego, USA) which compares use of a rotary evaporator and the Genevac Rocket Synergy evaporator, for the batch concentration of 2 L of winterised cannabis extract in ethanol.
Cannabis oil extract has been used medicinally for generations to help treat a variety of conditions, and its popularity has increased considerably in recent years. Of the various extraction methods used, ethanol extraction is increasingly becoming the method of choice because of its ability to economically and effectively produce an extract with a high terpene content that is safe for consumption.
In the video interview, Jim Bilotta of California Gold describes the protocols required to batch concentrate winterised cannabis extract in ethanol using both a rotary evaporator and a Genevac Rocket Synergy evaporator. Mr Bilotta confirms the considerable walkaway automation benefits of the Rocket Synergy evaporator both in terms of freeing staff to do other tasks and reproducibly producing a top quality cannabis oil extract.
Genevac Rocket and Rocket 4D Synergy evaporators set a new benchmark in evaporation versatility. Fitted with a stainless steel evaporation vessel either system can dry or concentrate batch volumes of up to 5L with no user intervention or attention. An auto-feed system on the Rocket 4D synergy extends capacity, enabling unattended automated processing of many tens of litres of product. For further operational versatility the bowl rotor may be quickly removed and replaced with a six position flask rotor to accommodate the full range of Rocket Sample handling solutions such as flasks, tubes and SampleGenie.
Five times faster than other 'intelligent' evaporators, the Rocket Synergy evaporator is capable of replacing several rotary evaporators, from benchtop to 50- L capacity, saving valuable bench space and improving your productivity.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.